The Compability Level of Tuberculin Skin Test and T-SPOT.TB, Sensitivity and Spesifisity of T-SPOT.TB in Detecting Latent Tuberculosis in Hemodialysis Patients
DOI:
https://doi.org/10.36497/jri.v41i1.159Keywords:
LTBI, TST, T-Spot.TB, CD4 Cells, HemodialysisAbstract
Background: Controling Latent Tuberculosis Infection (LTBI) is important for the End TB Strategy program. The prevalence of LTBI and reactivation to active tuberculosis are increased in immunodeficiency conditions, such on hemodialialysis patients. Laten tuberculosis can be diagnosted by Tuberculin Skin Test (TST) and immunoglobulin release assay (IGRA). This diagnostic study aimed to determine the agreement level of TST and T-SPOT.TB, accurancy of T-SPOT.TB, and the correlation between T cluster of differentiation 4 (CD4+) cell counts with TST and T-SPOT.TB. Methods: This is a cross sectional study design was performed in hemodialysis patients of Dr. Moewardi Surakarta Hospital in May 2018. The study subject had TST and T-SPOT.TB examinations by using 2 Tuberkulin Unit (TU) of intradermal purified protein derivate (PPD) RT 23 (Biofarma, Bandung) and venous blood ELISPOT analysis, respectively. Statistical analysis used windows SPSS 21. Results: There were 30 study subjects. The prevalence of LTBI was 23.3%. The agreement level of TST and T-SPOT.TB was substantial (K=0.667;P<0.001). The sensitivity and specificity of T-SPOT.TB were 66.7% and 95.8%, respectively. There were no significant correlation of CD4+ T cell counts with TST (R=0,253;P=0,177), T-SPOT.TB ESAT-6SFUs (R=-0.169;P=0.317), T-SPOT.TB CFP-10 SFUs (R=0.006;P=0.975), and the highest value of T-SPOT.TB ESAT-6/CFP-10 SFUs, (R=-0.070;P=0.741). Conclusion: The prevalence of LTBI is high in hemodialysis patients, thus early detection is necessary. TST examination is recommended for LTBI diagnostic tool in hemodialysis patients because of its practical use, inexpensive, and does not require skilled personnel.Downloads
References
World Health Organization. Global Tuberculosis Report 2017. Geneva: WHO Press; 2017. p. 1-262.
Esmail H, Barry CE, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Trans R Soc. 2015;369:1-14.
Centers for Disease Control and Prevention. Core curiculum on tuberculosis: what the clinician should know. 6th ed. Atlanta: Centers for Disease Control and Prevention National; 2013. p. 1-320.
Perhimpunan Dokter Paru Indonesia. Pedoman tatalaksana infeksi TB laten. Jakarta: Perhimpunan Dokter Paru Indonesia; 2016. p. 1-38.
Moore DAJ, Lightstone L, Javid B, Friedland JS. High rates of tuberculosis in end stage renal failure: the impact of international migration. Emerging Infect Dis. 2002;8(1):77-8.
Abdel-Nabi EA, Eissa SA, Soliman YMA, Amin WA. Quantiferon vs tuberculin testing in detection of laten tuberculous infection among chronic renal failure patients. Egypt J Chest Dis and Tuberculosis. 2014;63:161-5.
Oxford Immunotec. T-SPOT.TB frequently asked questions [Internet]. 2017 [cited 2017 Mar 9]. Available from: www.tspot.com/wp-content/uploads/2017/03/TSPOT_FAQ_Booklet.pdf.
Shu CC, Wu VC, Yang FJ, Pan SC, Lai TS, Wang JY, et al. Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis. Plos One. 2012;7(8):1-6.
Lee SSJ, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, et al. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of Quantiferon–TB Gold, ELISPOT, and Tuberculin Skin Test. Infection. 2009;37(2):96-102.
Passalent L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Detecting latent tuberculosis infection in hemodialysis patients: a head to head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel. Clin J Am Soc Nephrol. 2007;2(1):68-73.
Triverio PA, Bridevaux PO, Roux LP, Niksic L, Rochat T, Martin PY, et al. Interferon-gamma release assay versus tuberculin skin testing for detection of laten tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant. 2009;24:1952-6.
Chung WK, Zeng ZL, Sung JY, Kim S, Lee HH, Choi SJ, et al. Validity of interferon-γ-release assay for the diagnosis of latent tuberculosis in haemodialysis patients. Clin Microl Infect. 2010;16:960-5.
Soysal A, Toprak D, Koc M, arikan H, Akoglu E, Bakir M. Diagnosing laten tuberculosis infection in haemodyalisis patients: T-cell based assay (T-SPOT.TB) or tuberculin skin test?. Nephrol Dial Transplant. 2012;27:1645-50.
Ahmad S. Pathogenesis, immunology, and diagnosis of latent mycobacterium tuberculosis infection. Clin and Develop Immunol. 2011;10:1-17.
Mancuso JD, Mody RM, Olsen CH, Harrison LH, Santosham M, Aronson NE. The long-term effect of bacille calmette-guerin vaccination on tuberculin skin testing: a 55-year follow up study. Chest. 2017;152(2):282-94.
Hizel K, Maral I, Karakus R, Aktas F. The influence of BCG immunisation on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis. Clin Microbiol Infect. 2004;10:980-3.
Hussein MT, Yousef LM, Ali AT. Detection of latent tuberculosis infection in hemodialysis patients: comparison between the quantiferon-tuberculosis gold test and tuberculin skin test. Egypt J Bronchol. 2017;11:255-9.
HenDr.ikx TK, Van Gurp EAFJ, Mol WM, Schoordijk W, Sewgobind VDKD, Ijermans JNM, et al. End stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T cells. Nephrol Dial Transplant. 2009;24:2279-85.
Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22(1):149-56.
Kussen GMB, Dalla-Costa LM, Rossoni A, Raboni SM. Interferon-gamma release assay versus tuberculin skin test for latent tuberculosis infection among HIV patients in Brazil.Braz Infect Dis. 2016;20(1):69-75.
Leidl L, Mayanja-Kizza H, Sotgiu G, Baseke J, Ernst M, Hirsch C, et al. Relationship of immunodiagnostic assays for tuberculosis and number of circulating CD4+ T-cells in HIV infection. Eur Respir J. 2010;35:619-26.
Downloads
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.